Bausch Health Companies (BHC) Return on Capital Employed (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Return on Capital Employed came in at 2.81% in Q1 2026, down 413.0% year-on-year from 0.9% in Q1 2025, and down 65.28% quarter-over-quarter from 8.09% in Q4 2025.
Bausch Health Companies (BHC) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Return on Capital Employed across 17 years of filings, most recently posting 2.81% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 2.81%, down 413.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.81% (down 413.0% YoY), and the FY2025 annual result was 8.14%, up 48.0% from the prior year.
- Return on Capital Employed came in at 2.81% for Q1 2026 at Bausch Health Companies, down from 8.09% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 8.53% in Q3 2025 to a low of 1.59% in Q1 2023.
- The 5-year median for Return on Capital Employed is 4.68% (2024), against an average of 4.92%.
- Across the five-year window, Return on Capital Employed surged 602 bps in 2022 and plunged 413 bps in 2026, its largest moves.
- Bausch Health Companies' Return on Capital Employed stood at 2.06% in 2022, then surged by 104 bps to 4.2% in 2023, then surged by 86 bps to 7.82% in 2024, then climbed by 3 bps to 8.09% in 2025, then slumped by 65 bps to 2.81% in 2026.
- The last three Return on Capital Employed figures came in at 2.81% (Q1 2026), 8.09% (Q4 2025), and 8.53% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 2.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.81% |
| Dec 31, 2025 | 8.09% |
| Sep 30, 2025 | 8.53% |
| Jun 30, 2025 | 7.30% |
| Mar 31, 2025 | 6.94% |
| Dec 31, 2024 | 7.82% |
| Sep 30, 2024 | 6.13% |
| Jun 30, 2024 | 4.68% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 4.20% |
| Sep 30, 2023 | 1.65% |
| Jun 30, 2023 | 2.77% |
| Mar 31, 2023 | 1.59% |
| Dec 31, 2022 | 2.06% |
| Sep 30, 2022 | 4.52% |
| Jun 30, 2022 | 5.87% |
| Mar 31, 2022 | 3.92% |
| Dec 31, 2021 | 1.87% |
| Sep 30, 2021 | 0.32% |
| Jun 30, 2021 | -0.15% |